Edoxaban Plus Aspirin vs Dual Antiplatelet Therapy in Endovascular Treatment of Patients With Peripheral Artery Disease: Results of the ePAD Trial

Purpose: To report a randomized study that investigated the safety (risk of major bleeds) and potential efficacy of edoxaban, an oral anticoagulant that targets the major components of arterial thrombi, to prevent loss of patency following endovascular treatment (EVT). Methods: Between February 2012...

Descripción completa

Detalles Bibliográficos
Autores principales: Moll, Frans, Baumgartner, Iris, Jaff, Michael, Nwachuku, Chuke, Tangelder, Marco, Ansel, Gary, Adams, George, Zeller, Thomas, Rundback, John, Grosso, Michael, Lin, Min, Mercur, Michele F., Minar, Erich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Lower Limb Interventions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862321/
https://www.ncbi.nlm.nih.gov/pubmed/29552984
http://dx.doi.org/10.1177/1526602818760488

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862321/
https://www.ncbi.nlm.nih.gov/pubmed/29552984
http://dx.doi.org/10.1177/1526602818760488

Ejemplares similares